Hepatitis C treatment of african americans: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) (Created page with "{{Hepatitis C}} {{CMG}}; {{AOEIC}} {{VK}} ==Recommendations for Treatment of African Americans: AASLD Practice Guidelines 2009<ref name="pmid19554546">{{cite journal |author=...") |
m (Changes made per Mahshid's request) |
||
| Line 16: | Line 16: | ||
[[Category:Hepatitis|C]] | [[Category:Hepatitis|C]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 17:56, 18 September 2017
|
Hepatitis C |
|
Diagnosis |
|
Treatment |
|
Hepatitis C treatment of african americans On the Web |
|
American Roentgen Ray Society Images of Hepatitis C treatment of african americans |
|
Risk calculators and risk factors for Hepatitis C treatment of african americans |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
Recommendations for Treatment of African Americans: AASLD Practice Guidelines 2009[1]
| “ |
1. African Americans infected with HCV who are appropriate treatment candidates should be treated with the current optimal regimen consisting of pegylated interferon and ribavirin (Class I, Level A). 2. African Americans with baseline neutropenia (ANC <1500 mm3) should not be excluded from hepatitis C treatment (Class IIa, Level B). |
” |
References
- ↑ Swan T, Curry J (2009). "Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users". Hepatology (Baltimore, Md.). 50 (1): 323–4, author reply 324–5. doi:10.1002/hep.23077. PMID 19554546. Retrieved 2012-02-21. Unknown parameter
|month=ignored (help)